Understanding the characteristics of metabolic associated fatty liver disease
A Multicenter, Retrospective Clinical Study on the Clinical Characteristics of Metabolic Associated Fatty Liver Disease
This study looks at the different features and outcomes of metabolic associated fatty liver disease in patients to help create better prevention and treatment strategies, especially for younger people affected by it.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Trial ID | NCT06325254 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on metabolic associated fatty liver disease (MAFLD), which can lead to serious liver complications. It aims to systematically investigate the clinical features and prognosis of MAFLD patients, considering the variations in metabolic disorder phenotypes and treatment measures. By analyzing these characteristics, the study seeks to inform the development of targeted clinical prevention and treatment strategies for MAFLD. The study is particularly relevant given the rising incidence of MAFLD among younger populations due to lifestyle changes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 years or older diagnosed with metabolic associated fatty liver disease.
Not a fit: Patients with malignant tumors, severe mental illness, significant cardiopulmonary or renal impairment, severe infections, cerebrovascular accidents, or those who have received organ transplants may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved prevention and treatment strategies for patients with metabolic associated fatty liver disease.
How similar studies have performed: While there is ongoing research into MAFLD, this study's systematic approach to understanding clinical characteristics and prognosis is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 18 years or older; 2. MAFLD patients Exclusion Criteria: 1. malignant tumors; 2. mental illness, severe impairment of cardiopulmonary function, severe renal insufficiency, severe infections, and cerebrovascular accidents; 3. received liver or other organ transplants.
Where this trial is running
Nanjing, Jiangsu
- Nanjing Drum Tower Hospital — Nanjing, Jiangsu, China (Recruiting)
Study contacts
- Study coordinator: Jie Li, M.D.,Ph.D
- Email: lijier@nju.edu.cn
- Phone: 15863787910
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.